Mucopolysaccharide diseases: A complex interplay between neuroinflammation, microglial activation and adaptive immunity
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Mucopolysaccharide (MPS) diseases are lysosomal storage disorders (LSDs) caused by deficiencies in enzymes required for glycosaminoglycan (GAG) catabolism. Mucopolysaccharidosis I (MPS I), MPS IIIA, MPS IIIB and MPS VII are deficient in the enzymes α–L‐Iduronidase, Heparan‐N‐Sulphatase, N‐Acetylglucosaminidase and Beta‐Glucuronidase, respectively. Enzyme deficiency leads to the progressive multi‐systemic build‐up of heparan sulphate (HS) and dermatan sulphate (DS) within cellular lysosomes, followed by cell, tissue and organ damage and in particular neurodegeneration. Clinical manifestations of MPS are well established; however as lysosomes represent vital components of immune cells, it follows that lysosomal accumulation of GAGs could affect diverse immune functions and therefore influence disease pathogenesis. Theoretically, MPS neurodegeneration and GAGs could be substantiating a threat of danger and damage to alert the immune system for cellular clearance, which due to the progressive nature of MPS storage would propagate disease pathogenesis. Innate immunity appears to have a key role in MPS; however the extent of adaptive immune involvement remains to be elucidated. The current literature suggests a complex interplay between neuroinflammation, microglial activation and adaptive immunity in MPS disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurotrophins: Roles in Neuronal Development and Function
Huang, E. J., & Reichardt, L. F. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.677 · Cited by 4,394
The Danger Model: A Renewed Sense of Self
Matzinger, P. (2002) · Science · doi:10.1126/science.1071059 · Cited by 4,205
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110 · cited 2×
“TLR activation also induces the upregulation of the costimulatory molecules CD80 and CD86, along with MHC (which aid in T cell recruitment and activation), which would further amplify the immune response (Olson and Miller 2004; Block et al 2007; Pais et al 2008).”
Microglia: Active sensor and versatile effector cells in the normal and pathologic brain
Hanisch, U.-K., & Kettenmann, H. (2007) · Nature Neuroscience · doi:10.1038/nn1997 · Cited by 3,676 · cited 2×
“Microglia survey for injury within the CNS, and are involved in a range of homeostatic processes including phagocytosis of damaged neurons, antigen processing and presentation, along with neuroprotection and regeneration (Olson and Miller 2004; Hanisch and Kettenmann 2007; Neumann et al 2009; Walter and Neumann 2009).”
DAMPs, PAMPs and alarmins: all we need to know about danger
Bianchi, M. E. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306164 · Cited by 2,794 · cited 3×
“Cellular injury is recognised via the expression or secretion of damage associated molecular patterns (DAMPs) by conserved pattern recognition receptors (PRR), including toll-like receptors (TLRs), on immune cells (Pasare and Medzhitov 2005; Bianchi 2007; Piccinini and Midwood 2010).”
InfluentialStein, M., Keshav, S., Harris, N., & Gordon, S. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.1.287 · Cited by 1,960 · cited 1×
“Conversely, in the presence of IL-4, microglia can adopt an alternative activation state, characterised by expression of macrophage mannose receptors (MMR), MHC II upregulation, along with portraying an antiinflammatory profile (Stein et al 1992; Butovsky et al 2005; Colton 2009).”
Inflammation is detrimental for neurogenesis in adult brain
Ekdahl, C. T., Claasen, J.-H., Bonde, S., Kokaia, Z., & Lindvall, O. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2234031100 · Cited by 1,559
Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs
Olson, J. K., & Miller, S. D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.3916 · Cited by 1,215
Debris clearance by microglia: an essential link between degeneration and regeneration
Neumann, H., Kotter, M. R., & Franklin, R. J. M. (2008) · Brain · doi:10.1093/brain/awn109 · Cited by 1,111 · cited 1×
“…injury within the CNS, and are involved in a range of homeostatic processes including phagocytosis of damaged neurons, antigen processing and presentation, along with neuroprotection and regeneration (Olson and Miller 2004; Hanisch and Kettenmann 2007; Neumann et al 2009; Walter and Neumann 2009).”
Lysosomal Glycosphingolipid Recognition by NKT Cells
Zhou, D., Mattner, J., Cantu, C., Schrantz, N., Yin, N., Gao, Y., Sagiv, Y., Hudspeth, K., Wu, Y.-P., Yamashita, T., et al. (2004) · Science · doi:10.1126/science.1103440 · Cited by 956 · cited 1×
“…selection and activation can be impaired by lysosomal lipid storage, as shown in glycosphingolipid (GSL) storage mice and Sandhoff disease mice (Zhou et al 2004; Gadola et al 2006). iNKT cells become activated upon recognition of an endogenous lipid ligand bound to the lysosomal derived CD1d…”
Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death
Boje, K. M., & Arora, P. K. (1992) · Brain Research · doi:10.1016/0006-8993(92)91004-x · Cited by 944 · cited 1×
“1) (Colton and Gilbert 1987; Boje and Arora 1992; Lee et al 1993; Liu et al 2002; Olson and Miller 2004; Butovsky et al 2005; Block et al 2007; Pais et al 2008).”
Butovsky, O., Ziv, Y., Schwartz, A., Landa, G., Talpalar, A. E., Pluchino, S., Martino, G., & Schwartz, M. (2006) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.10.006 · Cited by 923
Brain inflammation and adult neurogenesis: The dual role of microglia
Ekdahl, C. T., Kokaia, Z., & Lindvall, O. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.06.052 · Cited by 801
Mitchell, R. A., Liao, H., Chesney, J., Fingerle-Rowson, G., Baugh, J., David, J., & Bucala, R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012511599 · Cited by 622 · cited 1×
“MIF is an important macrophage survival factor associated with several inflammatory and neurodegenerative diseases (Mitchell et al 2002; Villani et al 2007; Bacher et al 2010; Cheng et al 2010; Kithcart et al 2010).”
Qin, L., Liu, Y., Wang, T., Wei, S.-J., Block, M. L., Wilson, B., Liu, B., & Hong, J.-S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307657200 · Cited by 574 · cited 2×
“Additionally, NADPH-oxidase knockout mice demonstrate a decrease in microglial activation and associated neurotoxicity (Qin et al 2004).”
CTLA-4 regulates induction of anergy in vivo
Greenwald, R. J., Boussiotis, V. A., Lorsbach, R. B., Abbas, A. K., & Sharpe, A. H. (2001) · Immunity · doi:10.1016/s1074-7613(01)00097-8 · Cited by 428 · cited 1×
“However as CTLA-4 is also present, this could be having an anergic effect on the T cells, thereby suppressing their proliferation (Alegre et al 2001; Greenwald et al 2001; DiRosario et al 2009).”
Butovsky, O. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26836 · Cited by 261 · cited 2×
“Severe inflammatory conditions, such as those stimulated by LPS, induce microglia to form a classical neurodestructive phenotype, which subsequently abrogates neurogenesis and oligodendrogenesis (Ekdahl et al 2003; Butovsky et al 2005; Butovsky et al 2006a, b).”
Fraldi, A., Annunziata, F., Lombardi, A., Kaiser, H., Medina, D. L., Spampanato, C., Fedele, A. O., Polishchuk, R., Sorrentino, N. C., Simons, K., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.237 · Cited by 225
Regulation of Proliferation, Differentiation and Survival by the IL-3/IL-5/GM-CSF Receptor Family
de Groot, R. P., Coffer, P. J., & Koenderman, L. (1998) · Cellular Signalling · doi:10.1016/s0898-6568(98)00023-0 · Cited by 215
Cited by
Inflammation in neurodegenerative diseases—An update
Amor, S., Peferoen, L. A. N., Vogel, D. Y. S., Breur, M., van der Valk, P., Baker, D., & van Noort, J. M. (2014) · Immunology · doi:10.1111/imm.12233 · Cited by 550
Tardieu, M., Zérah, M., Husson, B., de Bournonville, S., Deiva, K., Adamsbaum, C., Vincent, F., Hocquemiller, M., Broissand, C., Furlan, V., et al. (2014) · Human Gene Therapy · doi:10.1089/hum.2013.238 · Cited by 261
“The main inclusion criteria were (1) an age at inclusion of between 18 months and the end of the 6th year; (2) an onset of clinical manifestations related to MPSIIIA during the first 5 years of life; and (3) SGSH activity in peripheral blood cells and/or cultured fibroblast extracts of <10% control levels.”
BackgroundInfluentialTordo, J., O’Leary, C., Antunes, A. S. L. M., Palomar, N., Aldrin-Kirk, P., Basche, M., Bennett, A., D’Souza, Z., Gleitz, H., Godwin, A., et al. (2018) · Brain · doi:10.1093/brain/awy126 · Cited by 113
“substrates contribute to the pathology of the disease (Archer et al., 2014).”
BackgroundSelf-citation
Metadata
- Authors
- Archer, L. D., Langford‐Smith, K. J., Bigger, B. W., & Fildes, J. E.
- Venue
- Journal of Inherited Metabolic Disease
- Publisher
- Wiley
- Published
- 2013-05-08
- Volume
- 37
- Issue
- 1
- Pages
- 1-12
- ISSN
- 0141-8955 (ISSN-L)
- 1573-2665
- OpenAlex
- W1987561426
- Cited by
- 93
- References
- 19
- FWCI
- 5.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.